CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net cash provided by operating activities (Note 6)	$ 103,997	$ 46,677
Cash flows from investing activities:
Capital expenditures	(46,356)	(45,114)
Origination of finance receivables	(907,769)	(917,145)
Collections on finance receivables	841,914	890,852
Other investing activities	(289)	821
Net cash used by investing activities	(112,500)	(70,586)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes	0	693,276
Repayments of medium-term notes	0	(350,000)
Proceeds from securitization debt	0	547,706
Repayments of securitization debt	(234,178)	(310,640)
Borrowings of asset-backed commercial paper	334,561	0
Repayments of asset-backed commercial paper	(46,154)	(62,634)
Net increase (decrease) in unsecured commercial paper	58,794	(270,119)
Net (decrease) increase in deposits	(6,758)	51,822
Dividends paid	(24,385)	(24,123)
Repurchase of common stock	(107,812)	(96,767)
Other financing activities	7	69
Net cash (used) provided by financing activities	(25,925)	178,590
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(7,020)	3,820
Net (decrease) increase in cash, cash equivalents and restricted cash	(41,448)	158,501
Cash, cash equivalents and restricted cash, beginning of period	1,648,811	1,579,177
Net (decrease) increase in cash, cash equivalents and restricted cash	(41,448)	158,501
Cash, cash equivalents and restricted cash, end of period	1,607,363	1,737,678
Reconciliation of cash, cash equivalents and restricted cash on the Consolidated balance sheets to the Consolidated statements of cash flows:
Cash and cash equivalents	1,464,614	1,561,200
Restricted cash	129,745	164,965
Restricted cash included in Other long-term assets	13,004	11,513
Cash, cash equivalents and restricted cash per the Consolidated statements of cash flows	$ 1,607,363	$ 1,737,678